GlobeNewswire
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
📈
AI Sentiment
Highly Positive
8/10
- Home
- OBIO
as of 12-09-2025 4:00pm EST
$4.20
$0.19
-4.33%
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Chart Type:
Time Range:
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | NEW HOPE |
| Market Cap: | 172.1M | IPO Year: | N/A |
| Target Price: | $13.67 | AVG Volume (30 days): | 332.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.20 - $6.30 | Next Earning Date: | 11-10-2025 |
| Revenue: | $2,818,000 | Revenue Growth: | 6.46% |
| Revenue Growth (this year): | 36.43% | Revenue Growth (next year): | 2.56% |
AI-Powered OBIO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.42%
75.42%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Orchestra BioMed Holdings Inc. (OBIO)
Hochman David P
Buy
See Remarks
OBIO Nov 14, 2025
Avg Cost/Share
$4.07
Shares
5,000
Total Value
$20,350.00
Owned After
612,822
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hochman David P | OBIO | See Remarks | Nov 14, 2025 | Buy | $4.07 | 5,000 | $20,350.00 | 612,822 |
Latest Orchestra BioMed Holdings Inc. News
OBIO Breaking Stock News: Dive into OBIO Ticker-Specific Updates for Smart Investing
Compare OBIO vs Leading Stocks
See how OBIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OBIO Orchestra BioMed Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.